Deucravacitinib Post-marketing Surveillance in Patients With Psoriasis in Japan
Deucravacitinib Post-marketing Surveillance in Patients With Psoriasis in Japan
The purpose of this study is to determine the safety and effectiveness of deucravacitinib for the treatment of plaque psoriasis (PsO) in Japan participants.
Inclusion Criteria:
Exclusion Criteria:
Tosima-ku, Tokyo 171-0021, Japan